rapamycin
Showing 1 - 25 of 64
Perimenopausal Trial in New York (Rapamycin, Placebo)
Not yet recruiting
- Perimenopausal
- Rapamycin
- Placebo
-
New York, New YorkColumbia University Irving Medical Center / NewYork-Presbyterian
Apr 17, 2023
Sjögren's Syndrome Trial in Beijing (low-dose interleukin-2, rapamycin)
Recruiting
- Sjögren's Syndrome
- low-dose interleukin-2
- rapamycin
-
Beijing, Beijing, ChinaPeking university people's hospital
Dec 2, 2022
Vitiligo Trial in Charleston (Rapamycin, Placebo)
Recruiting
- Vitiligo
- Rapamycin
- Placebo
-
Charleston, South CarolinaMedical University of South Carolina
Aug 2, 2022
Mild Cognitive Impairment, Alzheimer Trial in San Antonio (Rapamycin, Placebo)
Recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
- Rapamycin
- Placebo
-
San Antonio, TexasGlenn Biggs Institute for Alzheimer's & Neurodegenerative Diseas
Oct 10, 2022
Insulin Sensitivity Trial in Copenhagen (other, procedure, drug)
Recruiting
- Insulin Sensitivity
- Exercise
- +3 more
-
Copenhagen, DenmarkUniversity of Copenhagen
Jun 20, 2022
Activated PI3K-delta Syndrome, Immunodeficiency Primary Trial in Shanghai (Rapamycin)
Recruiting
- Activated PI3K-delta Syndrome
- Immunodeficiency Primary
- Rapamycin
-
Shanghai, Shanghai, China
- +1 more
Mar 21, 2022
Amyotrophic Lateral Sclerosis Trial in Italy (Rapamycin, Placebo Oral Tablet)
Completed
- Amyotrophic Lateral Sclerosis
- Rapamycin
- Placebo Oral Tablet
-
Genova, Italy
- +7 more
Aug 9, 2022
Aging Trial in Chicago (Rapamycin, Placebo)
Recruiting
- Aging
- Rapamycin
- Placebo
-
Chicago, IllinoisAgelessRx
Sep 28, 2021
Diabetes, Type 1 Trial in Milan (Human pancreatic islet, ATG, Pegylated G-CSF)
Active, not recruiting
- Diabetes Mellitus, Type 1
- Human pancreatic islet
- +3 more
-
Milan, ItalyIRCCS San Raffaele Scientific Institute
Dec 1, 2022
Facial Angiofibroma, Tuberous Sclerosis Trial in Worldwide (rapamycin, )
Completed
- Facial Angiofibroma
- Tuberous Sclerosis
- rapamycin
- placebo
-
Phoenix, Arizona
- +16 more
Jul 26, 2022
Cancer of Breast Trial in San Antonio (Rapamycin)
Active, not recruiting
- Cancer of Breast
- Rapamycin
-
San Antonio, TexasUniversity of Texas Health Science Center San Antonio
Mar 6, 2022
Aging Trial in San Antonio (rapamycin)
Recruiting
- Aging
- rapamycin
-
San Antonio, Texas
- +1 more
May 17, 2022
Dermal Atrophy Trial in Philadelphia (Rapamycin)
Completed
- Dermal Atrophy
- Rapamycin
-
Philadelphia, PennsylvaniaDrexel Dermatology
Sep 21, 2021
Breast Cancer Trial in Beijing (Inetetamab, Rapamycin, Pyrotinib)
Not yet recruiting
- Breast Cancer
- Inetetamab
- +3 more
-
Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Jan 31, 2021
Diabetes, Type 1 Trial in Milan (rapamycin, Vildagliptin, Placebo 1)
Completed
- Diabetes Mellitus, Type 1
- rapamycin
- +3 more
-
Milan, ItalyIRCCS San Raffaele Scientific Institute
Nov 2, 2020
Crohn's Diseases Trial in Nanjing (Rapamycin)
Recruiting
- Crohn's Diseases
- Rapamycin
-
Nanjing, Jiangsu, ChinaMedical Center for Digestive Diseases, The Second Affiliated Hos
Oct 2, 2020
Angiofibromas, Tuberous Sclerosis Trial in Australia, United States (Placebo, Rapamycin)
Completed
- Angiofibromas
- Tuberous Sclerosis
- Placebo
- Rapamycin
-
Birmingham, Alabama
- +9 more
Sep 30, 2020
Pompe Disease Trial in Gainesville (genetic, drug, other)
Completed
- Pompe Disease
- Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase
- +7 more
-
Gainesville, FloridaClinical and Translational Research Building (CTRB), University
Mar 24, 2022
Pineoblastoma Trial in Regensburg (Temozolomide, Irinotecan, Dasatinib)
Completed
- Pineoblastoma
- Temozolomide
- +3 more
-
Regensburg, GermanyUniversity Hospital of Regensburg
Jul 29, 2021
Alcohol Use Disorder, Alcohol Dependence Trial in Charleston (Rapamycin, Placebo)
Completed
- Alcohol Use Disorder
- Alcohol Dependence
- Rapamycin
- Placebo
-
Charleston, South CarolinaMedical University of South Carolina
Jan 7, 2021
Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS), Respiratory Failure, Sars-CoV2 Trial in San Antonio (Rapamycin,
Withdrawn
- Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
- +2 more
- Rapamycin
- Placebo
-
San Antonio, Texas
- +1 more
May 27, 2021
Chronic GVHD, Acute GVHD, Steroid Refractory GVHD Trial in Leuven, Liège (Rapamycin, T regulatory cells)
Recruiting
- Chronic Graft-Versus-Host Disease
- +2 more
- Rapamycin
- T regulatory cells
-
Leuven, Vlaams-Brabant, Belgium
- +1 more
Apr 27, 2021
Brain and CNS Tumors Trial in Los Angeles (Rapamycin, Surgery, Supportive Care)
Completed
- Brain and Central Nervous System Tumors
- Rapamycin
- +2 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020
Neuroblastoma Recurrent Trial in Regensburg (Dasatinib, Rapamycin, Irinotecan)
Completed
- Neuroblastoma Recurrent
- Dasatinib
- +3 more
-
Regensburg, GermanyUniversity Hospital Regensburg, Department of Pediatric Hematolo
Oct 2, 2020
Bladder Cancer Trial in San Antonio (Rapamycin, Placebo Oral Tablet)
Withdrawn
- Bladder Cancer
- Rapamycin
- Placebo Oral Tablet
-
San Antonio, TexasUniversity of Texas Health Science Center at San Antonio
Jun 7, 2019